The Stanford School of Medicine unveiled a novel machine on Tuesday that treats cancer patients with a high degree of ...

Results from the OASIS 4 clinical trial last year showed that a new drug, elinzanetant, relieved hot flushes and night sweats that can occur because of the menopause or because of hormone treatment ...

Elinzanetant reduces the severity and frequency of hot flushes and night sweats among women with breast cancer regardless of ...

Menopause drug Elinzanetant cuts hot flush frequency and severity in breast cancer patients on any hormone therapy, providing a safer, non-hormonal relief.

Neurologist visit frequency was modestly higher among cancer cases than controls but declined over time in both settings, ...

High-frequency ultrasound (HFUS) has emerged as a valuable non-invasive imaging modality in dermatology, offering detailed visualisation of the skin’s layers and its pathologies. Its high resolution ...

Over the years, research has demonstrated that regular physical activity can actually help reduce cancer-related fatigue. Now ...